Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice? | Contrib Nephrol;160: 88-106, 2008. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice?

Craven, Rachel A; Banks, Rosamonde E.

Affiliation

Craven RA; Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, UK.

Contrib Nephrol ; 160: 88-106, 2008.

Article in En | MEDLINE | ID: mdl-18401164

Subject(s)

Carcinoma, Renal Cell/metabolism; Carcinoma, Renal Cell/therapy; Kidney Neoplasms/metabolism; Kidney Neoplasms/therapy; Proteomics/trends; Biomarkers/metabolism; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Proteomics / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Contrib Nephrol Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Proteomics / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Contrib Nephrol Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland